Psaras T, Honegger J, Buslei R, Saeger W, Klein D, Capper D, Meyermann R, Mittelbronn M
Department of Neurosurgery, University of Tuebingen, Germany.
Exp Clin Endocrinol Diabetes. 2007 Oct;115(9):610-5. doi: 10.1055/s-2007-984437.
Herein, we report the case of a 73-year old male patient who presented with two recurrences of a pituitary adenoma within a period of 15 years. The first tumor resection 15 years ago revealed a non-functioning pituitary macroadenoma. 11 years later, the first recurrence of the tumor was reoperated. Throughout the early course of the disease, he suffered from secondary adrenal insufficiency and required replacement therapy with hydrocortisone. Currently, he presented with the second recurrence and clinical examination revealed signs of Cushing's disease. This was clearly confirmed by endocrinological evaluation. A retrospective analysis of all histological and immunohistochemical slides rendered an adenoma exhibiting chromophobia, ACTH-positivity and features of atypia such as elevated p53 and Ki67 expression as well as nuclear polymorphism. According to the revised WHO classification it was classified as atypical type II silent corticotroph adenoma at the time of the first and second surgery. The specimen removed during the recent surgery displayed the same histological features and was classified as corticotroph adenoma. The combination of an atypical type II adenoma and the switch in the hormone status to an endocrinologically active adenoma makes this case exceedingly rare.
在此,我们报告一例73岁男性患者,其垂体腺瘤在15年内复发了两次。15年前的首次肿瘤切除显示为无功能垂体大腺瘤。11年后,肿瘤首次复发并再次接受手术。在疾病早期,他患有继发性肾上腺皮质功能不全,需要氢化可的松替代治疗。目前,他出现了第二次复发,临床检查显示有库欣病的体征。内分泌评估明确证实了这一点。对所有组织学和免疫组织化学切片进行回顾性分析,发现腺瘤表现为嫌色性、ACTH阳性以及非典型特征,如p53和Ki67表达升高以及核多形性。根据世界卫生组织修订分类,在首次和第二次手术时该腺瘤被归类为非典型II型静止性促肾上腺皮质激素腺瘤。近期手术切除的标本显示出相同的组织学特征,被归类为促肾上腺皮质激素腺瘤。非典型II型腺瘤与激素状态转变为内分泌活跃腺瘤的组合使得该病例极为罕见。